00775.HK
CK Life Sciences Int'l., (Holdings) Inc.
HKSE · Healthcare · Biotechnology · HK
HKD 0.59
+0.85%Aug 11, 2026, 09:44 UTC
CK Life Sciences International reported interim results for the six months ended June 2026, with revenue of HK$2.716 billion, up 4.2% year-on-year, and a narrowed net loss of HK$28.73 million, compared with a loss of HK$151 million in the same period last year.
Source: